About us
We are passionate about bringing the lab to the patient.
We are passionate about bringing the lab to the patient.
CEO
Hans Brons is a business leader with more than 30 years of industry experience. and a passion for fast-growing technology-based start-up and scale-up companies. Hans led Nemo Healthcare BV and Medis Medical Imaging Systems BV. Even before, Hans served as CEO/Founder of IREX Technologies BV and IRX Innovations BV and held various leadership roles at Philips Electronics NV and at AT&T Network Systems BV for ten and four years, respectively. Hans obtained his MSc degree in Economics from the University of Tilburg (NL) and his MBA degree from Bradford University (UK).
CSO
Waander has over 30 years of experience as an expert in coagulation. He successfully founded and managed a spin-off company for 5 years and generated over €3M in contract research revenues for the Radboudumc. He was an inventor on 7 patent applications, and was part of over 80 scientific publications, inamongst others NEJM, Lancet and Blood. He is a former member of the International Society on Thrombosis and Hemostasis Standardization, Sub Committee “Fibrinolysis”, and a previous member of the scientific advisory board for the Dutch Thrombosis Foundation.
Director IVD Development
Rachel is an experienced product developer with a demonstrated history of working in the medical device industry. Skilled in assay development; from (pre)feasibility, through verification & validation (V&V) to the actual registration of a product. She loves to solve complex challenges in a creative, innovative and responsible way. After her PhD in Immunology at the Dutch Vaccine Institute (now part of the National Institute for Public Health and the Environment), she joined Organon / MSD and worked on the development of a small molecules-based medicine for the treatment of Rheumatoid Arthritis. At Organon, she valued the importance of quality during development. In 2015, she joined Future Diagnostics as a project leader focusing on assay development for third parties. She, successfully, helped developing the Minicare system of Siemens (formally Philips).
By bringing the lab to the patient, we can improve the quality of life without increasing healthcare costs.
Save patients from bleeding to death.
Develop a handheld device that can run multiple assays in parallel to identify the cause of a bleed so therapy can be adjusted without delay.
Our team of experts is innovating near patient diagnostics with a focus on blood coagulation.
Enzyre is always looking for collaborations to expand use of its platform technologies. Interested parties are encouraged to contact us at info@enzyre.com.
Get involved
Enzyre BV
Transistorweg 5
6534-AT Nijmegen
The Netherlands
